Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials
2018 · JNCI Journal of the National Cancer Institute · 47 citations
https://doi.org/10.1093/jnci/djy111
N
Nikki Burdett
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
224
Citations
7
h-index
7
i10-index
Nikki Burdett is an academic researcher. The author has contributed to research in topics: DNA Repair Mechanisms & PARP inhibition in cancer therapy & Cancer Genomics and Diagnostics. The author has an h-index of 7, co-authored 22 publications.
ORCID: 0000-0001-8581-2048Papers by this author
worksNew biomarkers for checkpoint inhibitor therapy
2020 · ESMO Open · 22 citations
https://doi.org/10.1136/esmoopen-2019-000597
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-50137-y
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-50137-y
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-48153-x
Comparison of homologous recombination deficiency scoring methods in multi-site samples in high grade serous ovarian cancer
2026 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2025.104233
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat